Neurogenic bladder

Neurogenic bladder is a functional disorder associated with a disruption of the innervation of the bladder, which leads to a change in the normal regulation of its activity. This condition can occur as a result of various neurological diseases, spinal cord injuries, strokes, and in patients with multiple sclerosis or diabetic neuropathy. The main problem in neurogenic bladder is the disruption of urine storage and excretion, which can manifest as urinary incontinence, urinary retention, or incomplete emptying of the bladder. These disorders can significantly affect the patient's quality of life, leading to physical, emotional, and social consequences.

History of the disease and interesting historical facts

The history of neurogenic bladder research goes back to ancient times. The first mention of urinary disorders associated with the nervous system can be found in the works of Hippocrates. However, systematic studies of neurogenic diseases began only in the 19th century, when neurophysiology began to develop as an independent discipline. Interesting facts include experiments on the innervation of the bladder in animals, conducted by scientists such as Charles Bernard and Gustav Thon. In the 20th century, significant progress in understanding neurogenic bladder was made thanks to the research of specialists such as David Gravy and Tomi Matsushita, who developed new methods for diagnosing and treating such conditions.

Epidemiology

The epidemiology of neurogenic bladder varies across populations and geographic regions. According to the World Health Organization, approximately 1-3% of the population suffers from various forms of urinary dysfunction associated with neurological diseases. Spinal cord injury is one of the most common factors leading to neurogenic bladder dysfunction, with 30% to 80% of such patients reporting associated urinary problems. Statistics show that among patients with multiple sclerosis, neurogenic bladder is observed in approximately 50-90% patients. In addition, diabetic neuropathy is a common cause of this condition among patients with type 2 diabetes, indicating a high prevalence of neurogenic dysfunction among diabetics.

Genetic predisposition to this disease

Genetic predisposition to neurogenic bladder is currently being studied, but it is believed that the condition is more often associated with acquired disorders than with hereditary factors. In some cases, mutations have been identified in genes responsible for the structure and function of neurons, such as the RHOA gene, which may influence the development of neuropathies. Also, genetic factors predisposing to autoimmune diseases may be related to neurological lesions causing bladder dysfunction. Studies show that patients with a family history of multiple sclerosis or other neurological diseases may have a higher risk of developing neurogenic bladder dysfunction.

Risk factors for the development of this disease

There are several risk factors that contribute to the development of neurogenic bladder:

• Neurological diseases: multiple sclerosis, Parkinson's disease, stroke.
• Spinal cord injuries: road traffic accidents and falls.
• Diseases associated with diabetic neuropathy.
• Certain pelvic surgeries that may cause nerve damage.
• Hereditary predisposition" the presence of relatives with neurological diseases.

These factors can directly affect the innervation of the bladder, as well as indirectly, increasing the risk of concomitant diseases.

Diagnosis of this disease

Diagnosis of neurogenic bladder involves a comprehensive examination taking into account clinical symptoms and laboratory methods. The main symptoms include:

• Urinary incontinence.
• Urinary retention and need for catheterization.
• Frequent urge to urinate.
• Incomplete emptying of the bladder.

Laboratory tests such as urinalysis and residual urine testing are standard. Radiological examinations such as ultrasound and cystoscopy allow evaluation of the anatomical changes and functional aspects of the bladder. Other diagnostics may include neurophysiological tests such as electroneuromyography. Differential diagnosis is important to exclude other diseases such as infections, tumors, or bladder stones.

Treatment

Treatment for neurogenic bladder varies and includes:

• General treatment: lifestyle changes, drinking regimen, bladder training.
• Pharmacological treatment: anticholinergic drugs, beta-3 adrenergic agents.
• Surgical treatment: various types of operations to correct innervation disorders, installation of systems to control urination.
• Other treatments include physical therapy and electrical stimulation of the bladder to improve bladder function.

It is important to take into account the individual characteristics of the patient and the mechanism of the disease when choosing treatment tactics.

List of medications used to treat this disease

The following medications are used to treat neurogenic bladder:

• Oxybutynin is an anticholinergic drug that reduces bladder spasticity.
• Tolterodine is a drug that helps reduce the frequency of urination.
• Mirabegron is a beta-3 adrenergic agonist that improves urine storage function.
• Duloxetine - may be used to improve urinary control in cases of mixed incontinence.

These medications help reduce symptoms and improve the quality of life of patients.

Disease monitoring

Neurogenic bladder monitoring includes regular observation of the patient's condition, assessment of bladder function, and monitoring for possible complications. It is important to regularly assess residual urine, monitor for urinary tract infections, and adjust treatment if necessary. The prognosis depends on the etiology of neurogenic dysfunction, the diagnosis, and the treatment performed. Major complications may include urinary tract infections, development of renal failure, and deterioration in quality of life.

Age-related features of the disease

Neurogenic bladder may present differently depending on the age of the patient. In children, the condition is often related to congenital disorders or trauma. In young adults and adults, the condition is usually caused by trauma or neurological disorders. In older patients, the disorder may be related to age-related changes in the nervous system and comorbidities. Treatment and monitoring should be tailored to the patient’s age and overall health.

Questions and Answers

• What is neurogenic bladder? Neurogenic bladder is a disorder of bladder function caused by damage to the nervous system, which results in changes in normal urination.
• What are the main symptoms of neurogenic bladder? The main symptoms include urinary incontinence, urinary retention, frequent urge to urinate, and incomplete emptying of the bladder.
• How is neurogenic bladder diagnosed? Diagnosis includes clinical examination, urinalysis, ultrasound and neurophysiological testing.
• What is the treatment for neurogenic bladder? Treatment includes lifestyle changes, drug therapy, surgical techniques and physical therapy.
• What is the prognosis for patients with neurogenic bladder? The prognosis depends on the cause of the disease and can vary; complications such as urinary tract infections and kidney failure are possible.